About Us

Support Us

Research Awards
   Award Recipients
   Apply for an Award

   Clinical Network
   Preclinical Screening

News Room
   What's New
   Advance Newsletter
   In the News
   Media Kit

   Learn from the Experts
   Clinical Trials
   Additional Resources

Contact Us


Project Awards


Investigator Institution Project
Terri S. Armstrong, DSN, APRN, BC*   M.D. Anderson Cancer Center   Gauging Impact of Treatment on Symptoms, Health Related Quality of Life and Neurocognitive Function in Patients with Primary Brain Tumors
Martin Brown, PhD   Stanford University   Sensitization of brain tumors to radiotherapy
Santosh Kesari, MD, PhD   Dana-Farber Cancer Institute   Notch inhibition in malignant gliomas
Ingo Mellinghoff, MD   University of California Los Angeles   Developing biomarkers for oncogenic EGFR signaling in glioblastoma
Keith Rich, MD   Washington University   Transglutaminase 2 inhibitor, KCC009, sensitizes glioblastomas to chemotherapy
John Sampson, MD, PhD   Duke University   Inactivation of regulatory T-cells to enhance immunotherapy against cytomegalovirus antigens in glioblastoma multiforme
Qing-Bai She, PhD   Memorial Sloan-Kettering Cancer Center   Development of therapeutic strategies for the inhibition of PI3K/Akt kinase-mediated signaling pathways in glioblastoma
Al Yung, MD   MD Anderson Cancer Center   Evaluation of small molecule inhibitors of the PI3K/Akt pathway
* Jointly awarded by Accelerate Brain Cancer Cure and the Tug McGraw Foundation
Content copyright © 2008 Accelerate Brain Cancer Cure, Inc.